Clinical Trial Update: Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator [NA]

View source ↗

Summary

Completed clinical trial evaluating acute tear production after a single use of the Oculeve intranasal neurostimulator; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Keratoconjunctivitis Sicca

Drugs mentioned

• Oculeve Intranasal Neurostimulator

Snippet

Sponsor: Oculeve, Inc. | Conditions: Dry Eye Syndrome, Keratoconjunctivitis Sicca | NA | Status: COMPLETED | Results posted: 2017-10-25